I'm a veterinarian in a mixed animal practice, and I'm growing increasingly concerned about the rise of multi-drug resistant infections we're seeing, particularly in livestock, which has implications for both animal welfare and public health. Our current protocols for antibiotic use feel outdated. For other veterinary professionals, what evidence-based stewardship programs or treatment guidelines have you successfully implemented to reduce unnecessary antibiotic prescriptions while still ensuring effective care, and how do you communicate the importance of this shift to clients who expect immediate treatment?
Solid issue. Start with a formal antimicrobial stewardship plan that fits your practice: appoint a stewardship lead, set measurable goals, and audit prescribing patterns quarterly. Begin with a culture-guided approach for livestock infections, cap broad-spectrum use, and move toward shorter, guideline-concordant courses. Roll out staff training and simple flowcharts for common conditions.
Key steps:
- Baseline audit of antibiotic prescriptions by species and indication; track Days of Therapy (DOT) per 1000 animal-days.
- Develop facility-specific guidelines mirroring AVMA/AAHA recommendations; require culture before prescribing for livestock when possible.
- Use a 'culture first' policy; implement short-interval reassessments (48–72h) to adjust.
- Create a post-prescription review process; provide feedback to veterinarians; track outcomes.
- Build a plan for injectable vs oral therapy and optimize dosing windows to minimize duration.
- Include de-escalation rules: switch to narrow-spectrum agents as soon as culture results are back.
Communicate with clients using plain language: explain that stewardship protects animal welfare and public health; present a simple rationale: testing to target drugs, shorter durations reduces resistance risk. Use a 1-page handout, simple visuals, and a short script for consultations. Offer follow-up checks and transparent withdrawal times where relevant to maintain trust.
Resources to get started:
- AVMA Guidelines for the Responsible Use of Antibiotics in Veterinary Medicine
- AAHA Antimicrobial Stewardship guidelines
- OIE/WAH prudent use guidance
- EFSA/EFSA ESVAC reports on veterinary antimicrobial use (where applicable)
- FDA Guidance for Industry #213 (US) and any local equivalents
- Local labs and diagnostic networks for timely culture testing
- Case studies or webinars from peer clinics implementing stewardship
Practical policy notes you can adapt:
- Implement a “first do no harm” policy: culture before broad-spectrum use when feasible, reserve critical antibiotics for confirmed needs.
- Create a restricted list for initial first-line options and a clinician-approved escalation path.
- Pair stewardship with preventive health: vaccines, biosecurity, improved husbandry to lower infection pressure.
- Engage producers with clear communication about withdrawal times, meat/milk safety, and long-term benefits of stewardship.
- Schedule quarterly reviews with a small task group to assess progress and adjust training materials.
Measurement that shows value:
- Days of Therapy (DOT) per 1000 animal-days and percentage of prescriptions guided by culture results.
- Reduction in average duration of therapy and changes in selection toward narrow-spectrum agents.
- Resistance trends from local labs and treatment outcomes (clinical cure rates, retreatment rates).
- Economic impact: treatment costs, hospitalization days, and producer satisfaction.
- A simple dashboard that can be shared with stakeholders, including farmers and regulatory bodies.
If you’d like, tell me your practice type (farm, companion-animal, mixed), your country, and any existing guidelines you already use. I can tailor a starter stewardship plan, a one-page client handout, and a quick 3-month rollout calendar.
One potential pitfall: culture results take time; communicate that stewardship is about smarter decisions, not withholding care in urgent cases. Consider a parallel track where acutely ill animals receive appropriate immediate care, with a plan for rapid culture-based adjustments when results return.